The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.
about
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab.Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD.
P2860
The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The successful use of alemtuzu ...... disease in pediatric patients.
@en
type
label
The successful use of alemtuzu ...... disease in pediatric patients.
@en
prefLabel
The successful use of alemtuzu ...... disease in pediatric patients.
@en
P2093
P2860
P356
P1476
The successful use of alemtuzu ...... disease in pediatric patients.
@en
P2093
Alexandra H Filipovich
Ashish Kumar
Jacob J Bleesing
Julia Lawrence
Kasiani Myers
Michael B Jordan
Michael S Grimley
Parinda Mehta
Pooja Khandelwal
Rebecca A Marsh
P2860
P304
P356
10.1111/PETR.12183
P577
2013-10-30T00:00:00Z